HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.

Abstract
Pharmacological characterization of NTE-122 (trans-1,4-bis[[1-cyclohexyl-3-(4-dimethylamino phenyl)ureido]methyl]cyclohexane), a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, was performed with both in vitro and in vivo assay systems. NTE-122 inhibited microsomal ACAT activities of various tissues (liver of rabbit and rat, small intestine of rabbit and rat, and aorta of rabbit) and cultured cells (HepG2 and CaCo-2), with IC50 values from 1.2 to 9.6 nM. The inhibition mode of NTE-122 was competitive for HepG2 ACAT. NTE-122 had no effect on other lipid metabolizing enzymes, such as 3-hydroxy-3-methylglutaryl-CoA reductase, acyl-CoA synthetase, cholesterol esterase, lecithin:cholesterol acyltransferase, acyl-CoA:sn-glycerol-3-phosphate acyltransferase and cholesterol 7alpha-hydroxylase up to 10 microM. When NTE-122 was administered to the cholesterol diet-fed rats, serum and liver cholesterol levels were markedly reduced with an ED50 of 0.12 and 0.44 mg/kg/day, respectively. In the cholesterol diet-fed rabbits, NTE-122 significantly lowered plasma and liver cholesterol levels at more than 2 mg/kg/day. These results indicate that NTE-122 is a potent, selective and competitive inhibitor of ACAT, making it a worth while therapeutic agent for hypercholesterolemia and atherosclerosis.
AuthorsY Azuma, T Kawasaki, K Ikemoto, K Obata, K Ohno, N Sajiki, T Yamada, M Yamasaki, Y Nobuhara
JournalJapanese journal of pharmacology (Jpn J Pharmacol) Vol. 78 Issue 3 Pg. 355-64 (Nov 1998) ISSN: 0021-5198 [Print] Japan
PMID9869270 (Publication Type: Journal Article)
Chemical References
  • Aniline Compounds
  • Cholesterol, Dietary
  • Cyclohexanes
  • Enzyme Inhibitors
  • NTE 122
  • Repressor Proteins
  • Saccharomyces cerevisiae Proteins
  • Cholesterol
  • Hydroxymethylglutaryl CoA Reductases
  • Cholesterol 7-alpha-Hydroxylase
  • Acyltransferases
  • Sterol O-Acyltransferase
  • Phosphatidylcholine-Sterol O-Acyltransferase
  • 1-Acylglycerol-3-Phosphate O-Acyltransferase
  • Sterol Esterase
  • Coenzyme A Ligases
  • FAA2 protein, S cerevisiae
  • long-chain-fatty-acid-CoA ligase
Topics
  • 1-Acylglycerol-3-Phosphate O-Acyltransferase
  • Acyltransferases (drug effects, metabolism)
  • Aniline Compounds (chemistry, pharmacology)
  • Animals
  • Caco-2 Cells
  • Cholesterol (metabolism)
  • Cholesterol 7-alpha-Hydroxylase (drug effects, metabolism)
  • Cholesterol, Dietary (administration & dosage)
  • Coenzyme A Ligases (drug effects, metabolism)
  • Cyclohexanes (chemistry, pharmacology)
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Hydroxymethylglutaryl CoA Reductases (drug effects, metabolism)
  • Male
  • Phosphatidylcholine-Sterol O-Acyltransferase (drug effects, metabolism)
  • Rabbits
  • Rats
  • Rats, Sprague-Dawley
  • Repressor Proteins
  • Saccharomyces cerevisiae Proteins
  • Sterol Esterase (drug effects, metabolism)
  • Sterol O-Acyltransferase (antagonists & inhibitors, metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: